OA08506A - Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function. - Google Patents

Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function.

Info

Publication number
OA08506A
OA08506A OA59095A OA59095A OA08506A OA 08506 A OA08506 A OA 08506A OA 59095 A OA59095 A OA 59095A OA 59095 A OA59095 A OA 59095A OA 08506 A OA08506 A OA 08506A
Authority
OA
OAPI
Prior art keywords
compounds
prophylaxis
treatment
disorders
agents containing
Prior art date
Application number
OA59095A
Other languages
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA08506A publication Critical patent/OA08506A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The invention relates to novel compounds having a nootropic activity, the use of ACE inhibitors as medicaments having nootropic activity, agents containing them, and their use in the treatment and prophylaxis of cognitive malfunctions.
OA59095A 1986-03-27 1987-03-27 Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function. OA08506A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (en) 1986-03-27 1986-03-27 COMPOUNDS WITH NOOTROPPER ACTION, THESE CONTAINERS AND THEIR USE IN THE TREATMENT AND PROPHYLAXIS OF COGNITIVE DYSFUNCTIONS

Publications (1)

Publication Number Publication Date
OA08506A true OA08506A (en) 1988-07-29

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59095A OA08506A (en) 1986-03-27 1987-03-27 Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function.

Country Status (25)

Country Link
EP (1) EP0243645B1 (en)
JP (1) JPS62240698A (en)
KR (1) KR870008841A (en)
CN (1) CN1031267C (en)
AT (1) ATE102954T1 (en)
AU (1) AU621278B2 (en)
CA (1) CA1341064C (en)
CS (2) CS212687A3 (en)
DD (1) DD280765A5 (en)
DE (2) DE3610391A1 (en)
DK (1) DK172221B1 (en)
EG (1) EG18175A (en)
ES (1) ES2061447T3 (en)
FI (1) FI91876C (en)
HU (2) HU203117B (en)
IE (1) IE62456B1 (en)
MA (1) MA20919A1 (en)
NO (1) NO178546C (en)
NZ (1) NZ219764A (en)
OA (1) OA08506A (en)
PH (1) PH27210A (en)
PT (1) PT84564B (en)
RU (1) RU1836335C (en)
TN (1) TNSN87045A1 (en)
ZA (1) ZA872230B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA1321753C (en) * 1987-04-27 1993-08-31 Abraham Sudilovsky Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (en) * 1987-09-16 1989-04-06 Hoechst Ag NEW AMINO ACID ESTERS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
DE3739690A1 (en) * 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
DE3801587A1 (en) * 1988-01-21 1989-08-03 Hoechst Ag NEW AMINO ACID GLYCERIDES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
EP0331609A3 (en) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin converting enzyme inhibitors having psychotropic effects
DE3803225A1 (en) * 1988-02-04 1989-08-17 Hoechst Ag AMINO ACID AMIDE WITH PSYCHOTROPIC EFFECT, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING THE SAME AND THEIR USE
JPH01275529A (en) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc Suppressing treatment agent of delayed motion effect
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
WO2002074293A2 (en) * 2001-03-15 2002-09-26 Saegis Pharmaceuticals Inc Methods for restoring cognitive function following systemic stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19575012I2 (en) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl dipeptides Process for their preparation and medicaments containing them
DE3300774A1 (en) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt NEW SPIROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AND NEW SPIROCYCLIC AMINO ACIDS AS INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
CS276179B6 (en) 1992-04-15
NO871282L (en) 1987-09-28
FI871304A0 (en) 1987-03-25
DE3610391A1 (en) 1987-10-08
JPS62240698A (en) 1987-10-21
PH27210A (en) 1993-05-04
EP0243645A3 (en) 1990-01-24
IE870784L (en) 1987-09-27
CN1031267C (en) 1996-03-13
ATE102954T1 (en) 1994-04-15
NO871282D0 (en) 1987-03-26
NO178546B (en) 1996-01-08
CS212687A3 (en) 1992-04-15
DK153587D0 (en) 1987-03-26
EP0243645A2 (en) 1987-11-04
PT84564A (en) 1987-04-01
MA20919A1 (en) 1987-10-01
CN87102304A (en) 1987-12-30
ZA872230B (en) 1987-09-21
RU1836335C (en) 1993-08-23
KR870008841A (en) 1987-10-21
AU621278B2 (en) 1992-03-12
DD280765A5 (en) 1990-07-18
HU203117B (en) 1991-05-28
AU7064987A (en) 1987-10-01
FI91876B (en) 1994-05-13
CS276385B6 (en) 1992-05-13
NO178546C (en) 1996-04-17
HU202118B (en) 1991-02-28
FI871304A (en) 1987-09-28
EP0243645B1 (en) 1994-03-16
DK153587A (en) 1987-09-28
IE62456B1 (en) 1995-02-08
CA1341064C (en) 2000-08-01
PT84564B (en) 1989-11-10
ES2061447T3 (en) 1994-12-16
DE3789330D1 (en) 1994-04-21
FI91876C (en) 1994-08-25
NZ219764A (en) 1990-11-27
HUT46046A (en) 1988-09-28
CS651989A3 (en) 1992-05-13
DK172221B1 (en) 1998-01-12
HU896609D0 (en) 1990-02-28
EG18175A (en) 1994-07-30
TNSN87045A1 (en) 1990-01-01

Similar Documents

Publication Publication Date Title
OA08506A (en) Compounds having a nootropic effect, agents containing these compounds, and their use in the treatment and prophylaxis of disorders of cognitive function.
FR2615394B1 (en) USE OF CERTAIN 17-CETOSTEROIDS, POSSIBLY WITH AN IMMUNOMODULATOR AND / OR ANTIVIRAL AGENT, TO MANUFACTURE A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF RETROVIRAL INFECTIONS
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
NL960024I2 (en) Pharmaceutical composition comprising 3'-deoxythymidine-2'-ene (3'-deoxy-2 ', 3'-didehydrothymidine) for the treatment of patients infected with retrovirus.
FR2541115B1 (en) MEDICAMENT CONTAINING PEPTIDE AS ACTIVE INGREDIENT FOR THE TREATMENT OF ULCEROUS CONDITIONS
FR2430408A1 (en) OPTICALLY ACTIVE PHENETHANOLAMINES AND THEIR THERAPEUTIC USE
EP0261595A3 (en) Pharmaceutical composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-didehydrocytidine) for treating patients infected with retrovirus
DE69330150D1 (en) Pharmaceutical compositions for transdermal administration of melatonin and / or its analogs
FR2398067A1 (en) NEW 4-PYRONES SUBSTITUTED IN POSITIONS 2, 3 AND 6 AND MEDICINAL PRODUCTS CONTAINING THEM
ES8604597A1 (en) Thiopyranopyrimidine compounds and acid addition salts thereof
IL89082A0 (en) Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
FR2575158B1 (en) ARYLALCOYLOXYMETHYL-2 MORPHOLINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
ATE72115T1 (en) APPLICATION OF 1,6-DIMETHYL-4-OXO-1,6,7,8,9A-
DE69109933T2 (en) Use of mizoribin to treat or prevent multiple sclerosis.
ATE94758T1 (en) USE OF GANGLIOSIDES TO TREAT AUTONOMOUS NERVOUS SYSTEM DYSFUNCTION IN CHAGAS DISEASE.
EP0228034A3 (en) Arginine and agmatine derivatives for treating protozoal infections
RO95371B1 (en) Medicament for treating chronic allergic diseases
ZA89574B (en) Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system